Pre-treatment lymphocytopaenia is an adverse prognostic biomarker in muscle-invasive and advanced bladder cancer
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Pre-treatment lymphocytopaenia is an adverse prognostic biomarker in muscle-invasive and advanced bladder cancer
Authors
Keywords
-
Journal
ANNALS OF ONCOLOGY
Volume 27, Issue 2, Pages 294-299
Publisher
Oxford University Press (OUP)
Online
2015-11-18
DOI
10.1093/annonc/mdv546
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The prognostic value of pretreatment of systemic inflammatory responses in patients with urothelial carcinoma undergoing radical cystectomy
- (2015) J H Ku et al. BRITISH JOURNAL OF CANCER
- Mechanism of Action of IL-7 and Its Potential Applications and Limitations in Cancer Immunotherapy
- (2015) Jianbao Gao et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Immune Response Regulation in the Tumor Microenvironment by Hypoxia
- (2015) Sara Labiano et al. SEMINARS IN ONCOLOGY
- Expression of hypoxia-inducible factor-1α predicts benefit from hypoxia modification in invasive bladder cancer
- (2014) B A Hunter et al. BRITISH JOURNAL OF CANCER
- MPDL3280A (anti-PD-L1) treatment leads to clinical activity in metastatic bladder cancer
- (2014) Thomas Powles et al. NATURE
- Prognostic Role of NLR in Urinary Cancers: A Meta-Analysis
- (2014) Yong Wei et al. PLoS One
- EAU Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2013 Guidelines
- (2013) J. Alfred Witjes et al. EUROPEAN UROLOGY
- Preoperative Neutrophil/Lymphocyte Ratio Predicts Overall Survival and Extravesical Disease in Patients Undergoing Radical Cystectomy
- (2013) L. Spencer Krane et al. JOURNAL OF ENDOUROLOGY
- Intratumor Hypoxia Promotes Immune Tolerance by Inducing Regulatory T Cells via TGF-β1 in Gastric Cancer
- (2013) Bin Deng et al. PLoS One
- Necrosis predicts benefit from hypoxia-modifying therapy in patients with high risk bladder cancer enrolled in a phase III randomised trial
- (2013) Amanda Eustace et al. RADIOTHERAPY AND ONCOLOGY
- Radiotherapy with or without Chemotherapy in Muscle-Invasive Bladder Cancer
- (2012) Nicholas D. James et al. NEW ENGLAND JOURNAL OF MEDICINE
- Hypoxia-inducible factor-1 alpha-dependent induction of FoxP3 drives regulatory T-cell abundance and function during inflammatory hypoxia of the mucosa
- (2012) E. T. Clambey et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Prognostic Value of Neutrophil-to-lymphocyte Ratio and Establishment of Novel Preoperative Risk Stratification Model in Bladder Cancer Patients Treated With Radical Cystectomy
- (2012) Tatsuo Gondo et al. UROLOGY
- Phase II Study of Conformal Hypofractionated Radiotherapy With Concurrent Gemcitabine in Muscle-Invasive Bladder Cancer
- (2011) Ananya Choudhury et al. JOURNAL OF CLINICAL ONCOLOGY
- Radiotherapy With Concurrent Carbogen and Nicotinamide in Bladder Carcinoma
- (2010) Peter J. Hoskin et al. JOURNAL OF CLINICAL ONCOLOGY
- Lymphopenia as a Prognostic Factor for Overall Survival in Advanced Carcinomas, Sarcomas, and Lymphomas
- (2009) Isabelle Ray-Coquard et al. CANCER RESEARCH
- Similar Treatment Outcomes for Radical Cystectomy and Radical Radiotherapy in Invasive Bladder Cancer Treated at a United Kingdom Specialist Treatment Center
- (2007) Sanjeev Kotwal et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now